Toggle Nav
mobile icon
My Cart
Close
  • Menu
  • Setting
  • Home
  • Signaling Pathways

Signaling Pathways

Items 11-20 of 76

Page
per page
  1. Azimilide
    B4849 Azimilide
    Summary: class III anti-arrhythmic drug
      insoluble in EtOH; insoluble in DMSO; ≥4.18 mg/mL
  2. Tolbutamide Sodium
    B4957 Tolbutamide Sodium
    Summary: potassium channel blocker
      Soluble in DMSO
  3. Retigabine
    B5888 Retigabine
    Summary: An activator of voltage-gated potassium channel, used as an anticonvulsant agent
  4. E-4031
    B6077 E-4031
    Summary: antiarrhythmic agent blocking the ATP-sensitive potassium channel
      insoluble in H2O; ≥103 mg/mL
  5. Hexachlorophene
    B6140 Hexachlorophene
    Summary: KCNQ1/KCNE1 potassium channel activator
      ≥40.7 mg/mL
  6. Verruculogen
    C4546 Verruculogen
    Summary: Maxi-K potassium channels inhibitor
      Soluble in ethanol;Soluble in methanol;Soluble in DMSO;Soluble in dimethyl formamide
  7. VU590 (hydrochloride)
    C4778 VU590 (hydrochloride)
    Summary: inhibitor of KCNJ1
      ≤20 mg/mL
  8. ML-297
    C5045 ML-297
    Summary: Selective Kir3.1/3.2 (GIRK1/2) channel activator
      ≤20 mg/mL
  9. Amiodarone HCl
    B1389 Amiodarone HCl
    Summary: Anti-arrhythmic drug
      insoluble in H2O; ≥68.33 mg/mL
  10. Mitiglinide Calcium
    B2193 Mitiglinide Calcium
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: Potassium channel inhibitor
      ≥33.45 mg/mL

Items 11-20 of 76

Page
per page